TY - JOUR
T1 - Gastro-oesophageal reflux: An overview of the cost-effectiveness of pharmacotherapeutic treatment options
T2 - An overview of the cost-effectiveness of pharmacotherapeutic treatment options
AU - Schellack, G.
AU - Meyer, Johanna Catharina
AU - Schellack, Natalie
N1 - Publisher Copyright:
© 2016 The Author(s).
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - © 2016 The Author(s). Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.
AB - © 2016 The Author(s). Gastro-oesophageal reflux disease (GORD) produces symptoms that cause great irritation to the patient. Pharmacotherapeutic management is directed at minimising these symptoms and reducing the causative factors, e.g. acid production, thereby providing relieve. Currently available agents include simple antacids and acid suppression therapy, including histamine 2-receptor antagonists, proton pump inhibitors, mucosal or cytoprotective agents, pro-motility agents. Deciding on appropriate therapy will be dependent on the diagnosis, side-effects and cost-effectiveness of the treatment.
KW - Cost-effectiveness
KW - GORD
KW - Gastro-oesophageal reflux
KW - PPIs
KW - Proton-pump inhibitors
UR - http://www.scopus.com/inward/record.url?scp=84978997442&partnerID=8YFLogxK
M3 - Literature review
SN - 2078-6190
VL - 58
SP - 18
EP - 24
JO - South African Family Practice
JF - South African Family Practice
IS - 2
ER -